Recent

% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • bdover23 bdover23 Nov 1, 2010 9:15 AM Flag

    Pre market trading

    The good news that you will hear on the conf call is that the profit share would have been $88M plus since 50% of the profit share first must be applied to repay sandoz for their investment in getting lovenox approved. The company estimates they will finish paying them back in the 4th quarter then the full share will be paid to MNTA.

    The estimates of the market share that teva (if ever approved, big if, since any arguement teva would make could be used against teva on copaxone) will take are way off. This drug is being marketed by Sandoz not MNTA so the best Teva could hope for is about 25% of the generic space (which teva would would be happy to take at a higher price then a price war that hurts both parties lot of money to share)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
MNTA
21.75-0.21(-0.96%)Jul 30 4:00 PMEDT